UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 3, 2005
SELECT MEDICAL CORPORATION
| Delaware | 000-32499 | 23-2872718 | ||
| (State or other jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055
(717) 972-1100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 8.01 Other Events | ||||||||
| Item 9.01 Financial Statements and Exhibits | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| PRESS RELEASE | ||||||||
| PRESS RELEASE | ||||||||
Item 8.01
|
Other Events |
On February 3, 2005, Select Medical Corporation (the “Company”) issued a press release announcing that the consent solicitation commenced in connection with the cash tender offer to purchase any and all of its outstanding $175 million principal amount of 9 1/2% Senior Subordinated Notes due 2009 and the consent solicitation commenced in connection with the cash tender offer to purchase any and all of its outstanding $175 million principal amount of 7 1/2% Senior Subordinated Notes due 2013 each had expired at 5:00 p.m., New York City time, on February 2, 2005. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Also on February 3, 2005, the Company issued a press release announcing that it had priced its offering of $660 million aggregate principal amount of Senior Subordinated Notes due 2015. A copy of the press release is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits |
(c) Exhibits.
| Exhibit No. | Description | |
99.1
|
Select Medical Corporation Press Release, dated February 3, 2005. | |
99.2
|
Select Medical Corporation Press Release, dated February 3, 2005. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| SELECT MEDICAL CORPORATION | ||||
Date: February 3, 2005
|
By: | /s/ Michael E. Tarvin | ||
| Michael E. Tarvin | ||||
| Senior Vice President, General Counsel and Secretary | ||||